DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Free Report) has earned a consensus rating of “Hold” from the thirteen ratings firms that are presently covering the firm, Marketbeat reports. Nine research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $26.33.
A number of analysts have issued reports on XRAY shares. StockNews.com raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Friday. Jefferies Financial Group cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $30.00 to $20.00 in a research report on Thursday, January 23rd. Needham & Company LLC boosted their target price on shares of DENTSPLY SIRONA from $23.00 to $25.00 and gave the stock a “buy” rating in a report on Thursday, January 30th. Leerink Partners lowered shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Thursday, November 7th. Finally, Morgan Stanley cut their target price on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a research note on Tuesday, December 17th.
View Our Latest Analysis on XRAY
DENTSPLY SIRONA Stock Down 1.6 %
DENTSPLY SIRONA Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, January 10th. Investors of record on Friday, December 27th were given a $0.16 dividend. The ex-dividend date of this dividend was Friday, December 27th. This represents a $0.64 dividend on an annualized basis and a yield of 3.47%. DENTSPLY SIRONA’s dividend payout ratio is currently -30.92%.
Institutional Inflows and Outflows
A number of large investors have recently bought and sold shares of the stock. First Eagle Investment Management LLC increased its position in shares of DENTSPLY SIRONA by 2.5% during the fourth quarter. First Eagle Investment Management LLC now owns 14,500,409 shares of the medical instruments supplier’s stock worth $275,218,000 after purchasing an additional 348,532 shares in the last quarter. Cooke & Bieler LP lifted its stake in DENTSPLY SIRONA by 24.3% during the 4th quarter. Cooke & Bieler LP now owns 9,172,876 shares of the medical instruments supplier’s stock worth $174,101,000 after acquiring an additional 1,794,391 shares in the last quarter. FMR LLC lifted its stake in DENTSPLY SIRONA by 5.1% during the 3rd quarter. FMR LLC now owns 9,056,774 shares of the medical instruments supplier’s stock worth $245,076,000 after acquiring an additional 436,031 shares in the last quarter. Pacer Advisors Inc. lifted its stake in DENTSPLY SIRONA by 15,105.1% during the 4th quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier’s stock worth $85,478,000 after acquiring an additional 4,473,972 shares in the last quarter. Finally, Bank of New York Mellon Corp raised its position in DENTSPLY SIRONA by 27.9% in the 4th quarter. Bank of New York Mellon Corp now owns 2,403,110 shares of the medical instruments supplier’s stock valued at $45,611,000 after purchasing an additional 523,692 shares in the last quarter. 95.70% of the stock is owned by institutional investors and hedge funds.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Featured Articles
- Five stocks we like better than DENTSPLY SIRONA
- What is a Dividend King?
- Merck: 4 No-Brainer Reasons to Buy This Dip
- What is the Euro STOXX 50 Index?
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- How to Buy Cheap Stocks Step by Step
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.